ENTELLUS MED INC's ticker is ENTL and the CUSIP is 29363K105. A total of 73 filers reported holding ENTELLUS MED INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $3,643,000 | +24.2% | 219,971 | +3.5% | 0.53% | +9.8% |
Q1 2017 | $2,932,000 | +604.8% | 212,491 | +868.1% | 0.48% | +530.3% |
Q4 2016 | $416,000 | -14.6% | 21,950 | 0.0% | 0.08% | -20.0% |
Q3 2016 | $487,000 | -7.6% | 21,950 | -23.9% | 0.10% | +72.7% |
Q2 2016 | $527,000 | +318.3% | 28,850 | +318.1% | 0.06% | +120.0% |
Q1 2016 | $126,000 | +38.5% | 6,900 | +28.4% | 0.02% | +31.6% |
Q4 2015 | $91,000 | – | 5,375 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SV Health Investors, LLC | 2,956,456 | $48,960,000 | 52.70% |
Discovery Group I, LLC | 2,169,729 | $35,931,000 | 10.38% |
Essex Woodlands Management, Inc. | 3,231,656 | $53,516,000 | 9.68% |
Archon Capital Management LLC | 478,820 | $7,929,000 | 6.46% |
First Light Asset Management, LLC | 512,416 | $8,486,000 | 2.85% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 341,468 | $5,655,000 | 2.15% |
Ghost Tree Capital, LLC | 375,000 | $6,210,000 | 1.29% |
PERKINS CAPITAL MANAGEMENT INC | 68,316 | $1,131,000 | 1.25% |
Cypress Capital Management LLC (WY) | 63,540 | $1,052,222,000 | 1.21% |
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 35,000 | $580,000 | 0.66% |